Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
  • Listen Now Playing Listen
NPR News

Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot

Keidy Ventura, 17, receives her first dose of the Pfizer COVID-19 vaccine in West New York, N.J. Pfizer has asked federal regulators to expand the eligibility for booster shots to include 16- and 17-year-olds.
Keidy Ventura, 17, receives her first dose of the Pfizer COVID-19 vaccine in West New York, N.J. Pfizer has asked federal regulators to expand the eligibility for booster shots to include 16- and 17-year-olds.

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today.

For the first time, people under the age of 18 may soon be eligible for a COVID-19 booster shot in the U.S.

On Tuesday, Pfizer CEO and Chairman Albert Bourla said the vaccine maker had submitted its request to the U.S. Food and Drug Administration to expand the emergency use authorization of a booster dose of the Pfizer-BioNTech COVID-19 vaccine to include 16- and 17-year-olds.

Bourla made the announcement on Twitter, saying that "it is our hope to provide strong protection for as many people as possible, particularly in light of the new variant" — a reference to omicron, which has not yet been detected in the U.S.

At the moment, only people 18 and older are eligible for a COVID-19 booster shot in the U.S., and it must be at least six months after receiving a second dose of either the Pfizer or Moderna vaccines. Adults 18 and older who received the Johnson & Johnson vaccine can get a booster after two months.

In October, Pfizer and BioNTech announced the results of a randomized study of 10,000 people 16 years of age and older that showed a booster dose "restored vaccine protection against COVID-19 to the high levels achieved after the second dose," according to a press release from the companies.

Pfizer's effort to expand eligibility for boosters to some adults under 18 comes as top federal health officials are urging all Americans who qualify to get a booster shot.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.

Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.

If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.

Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief

Make your tax-deductible donation today